GE Healthcare completes transfer of ownership of its four diagnostic imaging agents from Daiichi Sankyo

Tokyo, Japan and Chicago, US (March 2nd, 2020)GE Healthcare (Head Office: Chicago, US) today completed the transfer of ownership of its four diagnostic imaging agents in Japan from Daiichi Sankyo Company, Limited (Head Office: Chuo-ku Tokyo; Daiichi Sankyo).

Effective immediately, the four imaging agents, previously managed by Daiichi Sankyo, will be owned and managed by GE Healthcare Pharma Limited*, which will now be responsible for all aspects of their commercialization for Japanese hospitals and clinics.

List of transferred products

Imaging agents are administered to patients for Computed Tomography (CT), X-ray, Magnetic Resonance Imaging (MRI) or Ultrasound scans, to improve the images that radiologists use to diagnose and monitor disease. Under the terms of the agreement, Daiichi Sankyo, which has collaborated with GE Healthcare for over 30 years, will continue to distribute the products to drug wholesalers until March 2022, ensuring supply and delivery to medical facilities is unchanged.

About GE Healthcare

GE Healthcare is the $19.9 billion healthcare business of GE (NYSE: GE). As a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services. With over 100 years of experience in the healthcare industry and more than 50,000 employees globally, the company helps improve outcomes more efficiently for patients, healthcare providers, researchers and life sciences companies around the world. Follow us on FacebookLinkedInTwitter and Insights for the latest news, or visit our website www.gehealthcare.com for more information.

*GE Healthcare Pharma Limited is a newly established legal entity of GE Healthcare to run its Pharmaceutical Diagnostics business in Japan.

Media Contact
GE Healthcare Communications
David.J.Morris@ge.com

https://www.genewsroom.com/press-releases/ge-healthcare-completes-transfer-ownership-its-four-diagnostic-imaging-agents